Doctor of Osteopathy Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Cory Ullger

Pain Medicine Astoria, NY Doctor of Osteopathy

NPI 1720441660 CMS profile 9026716

3825 Astoria Blvd, Astoria, NY 11103

Open in the dashboard

General payments

$12,520

93 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cory Ullger of Astoria, NY is reported in the CMS Open Payments database as having received $12,520 across 93 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $383 3
2024 General $3,002 20
2023 General $4,472 46
2022 General $2,210 13
2021 General $2,453 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cory Ullger
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Cory Ullger were reported at $383. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Cory Ullger Pain Medicine median Middle half National median
2019 $0 $409 $115–$1,311 $163
2020 $0 $214 $66–$666 $114
2021 $2,453 $299 $84–$899 $132
2022 $2,210 $335 $103–$1,149 $149
2023 $4,472 $376 $114–$1,228 $160
2024 $3,002 $387 $115–$1,173 $164
2025 $383 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stratus Medical, LLC $3,513 29 payments
  2. Saluda Medical Americas, Inc. $2,878 21 payments
  3. Pacira Pharmaceuticals Incorporated $1,786 6 payments
  4. Spinal Simplicity, LLC $1,700 3 payments
  5. Nevro Corp. $901 11 payments
  6. Medtronic, Inc. $525 6 payments
  7. SPR Therapeutics, Inc $421 6 payments
  8. Curonix LLC $336 3 payments
  9. Vertos Medical, Inc. $182 2 payments
  10. Boston Scientific Corporation $145 1 payment
  11. Other $133 5 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,739 76 payments
  2. Travel and Lodging $4,250 15 payments
  3. Education $1,531 2 payments
Products named General payments · program years 2021–2025
  1. Nimbus $3,513 29 payments
  2. Evoke SCS $2,633 19 payments
  3. Iovera $1,786 6 payments
  4. HA MINUTEMAN G3-R $1,700 3 payments
  5. SPRINT PNS System $421 6 payments
  6. Senza $412 5 payments
  7. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $336 3 payments
  8. Omnia $308 3 payments
  9. Evoke $245 2 payments
  10. mild Device Kit $182 2 payments
  11. Other $979 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

50

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$624

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

64%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 11 $257
Oxycodone Hcl Generic 18 $186
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $180

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$267,221

Medicare's payments for the services billed

Medicare patients

423

Average age 80

Services billed

3,595

250 women, 173 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Alzheimer's or dementia 57%
Diabetes 52%
Ischemic heart disease 48%
Depression 46%
Heart failure 38%
Chronic kidney disease 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record